Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

OrganOx

Request full access

Normothermic organ perfusion system for liver transplantation

Oxford, United KingdomFounded 2008Health Tech & Medtech

About OrganOx

OrganOx is a medical technology company based in Oxford, United Kingdom, with a US base in Madison, New Jersey, that develops normothermic machine perfusion systems for donor organs. The company was spun out of the University of Oxford in 2008 by transplant surgeon Professor Peter Friend and biomedical engineer Professor Constantin Coussios, through the Institute of Biomedical Engineering and the Nuffield Department of Surgical Sciences, to address the shortage of viable organs for transplantation.

Its flagship product, the OrganOx metra, is a portable, automated device for normothermic machine perfusion of donor livers. Instead of storing the organ on ice, the system keeps the liver at body temperature and continuously perfuses it with oxygenated blood and nutrients, maintaining it in a metabolically active state outside the body. This allows transplant teams to assess organ function in real time before transplantation, extend preservation times, improve transplant logistics and use organs, including those from marginal donors, that might otherwise be discarded.

The metra platform is approved for clinical use in markets including the United States, Europe, Canada and Australia and has been used in thousands of liver transplants. OrganOx supplies its devices to specialist transplant centres together with the single-use disposable perfusion sets required for each procedure, and supports hospitals with clinical training and service.

Beyond liver preservation, the company is extending its perfusion technology to kidney transplantation and to organ support applications, including work combining the metra with genetically engineered porcine livers to support patients with acute-on-chronic liver failure. Its development work focuses on broadening the use of normothermic perfusion for organ assessment, repair and enhancement.

Source: Dealroom company data

OrganOx in the Oxford ecosystem

Live from Dealroom

The OrganOx office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Oxford Technology
  • Adam Niewinski
  • Technikos
  • Royal Society Enterprise Fund

Series B and later11 investors entered at this stage

  • Business Growth Fund
  • Lauxera Capital Partners
  • HealthQuest Capital
  • Terumo
  • Intuitive Ventures
  • Longwall Ventures
  • Avidity Partners
  • Soleus Capital
  • University of Oxford
  • Sofina
  • Piper Heartland Healthcare Capital
Employees mapped 242 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See OrganOx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.